CIGNA Co. (CI) Shares Bought by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lifted its position in shares of CIGNA Co. (NYSE:CI) by 3.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,611,743 shares of the health services provider’s stock after buying an additional 164,623 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 2.31% of CIGNA worth $953,716,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. E&G Advisors LP grew its position in shares of CIGNA by 33.3% during the 2nd quarter. E&G Advisors LP now owns 3,200 shares of the health services provider’s stock worth $544,000 after buying an additional 800 shares in the last quarter. Citizens Financial Group Inc RI grew its position in shares of CIGNA by 422.2% during the 2nd quarter. Citizens Financial Group Inc RI now owns 53,368 shares of the health services provider’s stock worth $9,070,000 after buying an additional 43,149 shares in the last quarter. Piedmont Investment Advisors LLC grew its position in shares of CIGNA by 79.7% during the 2nd quarter. Piedmont Investment Advisors LLC now owns 68,970 shares of the health services provider’s stock worth $11,721,000 after buying an additional 30,587 shares in the last quarter. Eqis Capital Management Inc. grew its position in shares of CIGNA by 66.0% during the 2nd quarter. Eqis Capital Management Inc. now owns 14,852 shares of the health services provider’s stock worth $2,524,000 after buying an additional 5,907 shares in the last quarter. Finally, Wealthstreet Investment Advisors LLC grew its position in shares of CIGNA by 12.8% during the 2nd quarter. Wealthstreet Investment Advisors LLC now owns 15,885 shares of the health services provider’s stock worth $2,700,000 after buying an additional 1,800 shares in the last quarter. 88.19% of the stock is currently owned by institutional investors and hedge funds.

CI stock traded down $0.35 during trading on Monday, reaching $176.90. 54,955 shares of the company traded hands, compared to its average volume of 1,848,398. CIGNA Co. has a 12 month low of $163.02 and a 12 month high of $227.13. The company has a market cap of $43.12 billion, a P/E ratio of 16.85, a PEG ratio of 1.11 and a beta of 0.62. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.35 and a quick ratio of 0.35.



CIGNA (NYSE:CI) last released its quarterly earnings results on Thursday, May 3rd. The health services provider reported $4.11 EPS for the quarter, beating analysts’ consensus estimates of $3.39 by $0.72. CIGNA had a return on equity of 20.90% and a net margin of 5.99%. The company had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.97 billion. During the same period last year, the business posted $2.77 earnings per share. The firm’s revenue was up 8.6% compared to the same quarter last year. analysts anticipate that CIGNA Co. will post 13.24 EPS for the current year.

In other CIGNA news, Director William D. Zollars sold 265 shares of the stock in a transaction dated Thursday, June 14th. The stock was sold at an average price of $176.93, for a total value of $46,886.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Hoeltzel Mary T. Agoglia sold 1,000 shares of the stock in a transaction dated Friday, May 25th. The shares were sold at an average price of $176.19, for a total value of $176,190.00. Following the completion of the sale, the vice president now owns 4,635 shares of the company’s stock, valued at $816,640.65. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

A number of brokerages recently weighed in on CI. ValuEngine downgraded CIGNA from a “hold” rating to a “sell” rating in a research report on Monday, July 2nd. Zacks Investment Research downgraded CIGNA from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 17th. Credit Suisse Group raised their price objective on CIGNA from $215.00 to $218.00 and gave the company an “outperform” rating in a research report on Friday, May 4th. Finally, Goldman Sachs Group raised CIGNA from a “neutral” rating to a “buy” rating and raised their price objective for the company from $193.00 to $212.00 in a research report on Wednesday, June 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $217.00.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

See Also: Understanding Price to Earnings Ratio (PE)

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply